Characteristic | All patients (N=21) |
Age, years | |
Mean | 58 |
Range | 35–75 |
Sex, no of patients (%) | |
Male | 14 (66.7%) |
Female | 7 (33.3%) |
ECGO performance status | |
0 | 21 |
1 | 0 |
Prior chemotherapy/radiotherapy | |
Yes | 3 |
No | 18 |
Primary site of disease | |
Stomach | 9 |
Colon and rectum | 12 |
Histologic type of primary tumor | |
Adenocarcinoma | 18 |
Adenocarcinoma with signet ring cell carcinoma | 3 |
Histologic grade/differentiation | |
Advanced-moderately differentiated | 1 |
Moderately differentiated | 14 |
Moderately poorly differentiated | 1 |
Poorly differentiated | 5 |
Stage | |
I | 2 |
II | 6 |
III | 8 |
IV | 5 |
RNAscope score | |
0 | 10 |
1 | 3 |
2 | 2 |
3 | 2 |
4 | 1 |
ECOG, Eastern Cooperative Oncology Group.